CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (348)	11/16/1999 12:50:00 AM
From: Vector1	of 666

PB, Unbelievable. Looks like Tidmarsh is taking the bullet for the filing problems. Great clinical results and they can not get the damm filing done. The SKB comment on the filing timeline came out a few weeks ago and was commented on in a few analyst reports and is why the the stock has been weak. I am perplexed with CLTR's and SKB's inability to get the filing completed. As Bob noted the initial results on the Fludarabine/Bex combi are very strong. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next